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Abstract
Background: Over the past decade several studies have questioned current standards of patient safety
in health care delivery. In response, our institution started a clinical pathway for total hip replacement in
1996. Prospective monitoring with regular feedback sessions to the individuals involved in patient care did
however not start until 2003. The present study evaluates the effect of prospective monitoring on
outcomes of total hip replacement.
Methods: Clinical records of patients undergoing primary elective total hip replacement between 1997
and 2004 were reviewed. Data on adverse events as well as adherence to protocols for venous
thromboembolism prophylaxis were extracted retrospectively for the period 1997 to 2001 and
prospectively from 2003 to 2004. Results were compared and analyzed in order to establish possible
improvement in outcomes. Data was analyzed with Chi-square or Fisher's Exact test for categorical
variables and Student's t-test for continuous variables. Alpha was set as less than 5% and analysis was
performed with Stata 9.0 for Macintosh.
Results: Two-hundred and eighty-three patients were included from 1997 to 2001, and 62 from 2003 to
2004. Mean age, male to female ratio and initial diagnosis were similar in both groups. At least one adverse
event occurred in 45% of patients in 1997–2001 and in 21% in 2003–2004 (p < 0.001). In-hospital hip
dislocations occurred in 6% and 0% (p = 0.05), oliguria in 19% and 5% (p = 0.007), SSI and VTE in 3% and
0% (p = 0.37), adverse drug reactions in 11% and 13% (p = 0.66) and non-adherence to VTE prophylaxis
protocols in 15% and 2% of cases respectively (p = 0.002).
Conclusion: Overall rate of adverse events as well as in-hospital hip dislocations, oliguria and non-
adherence to VTE prophylaxis protocols were significantly reduced during the second period. We
conclude that clinical pathways alone are insufficient to improve patient safety and require prospective
monitoring and continuous feedback to health care providers in order to achieve the desired effect.
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Background
The rise of malpractice claims over the last decades has
lead to an increased focus on adverse events and medical
error as an active field of study [1]. One large medical
injury study, the Harvard Medical Practice Study, found
that adverse events (AEs) occurred in 4% of hospitaliza-
tions. Furthermore, 28% of AEs were established as being
secondary to negligence. Most strikingly, this study
showed that 3% of AEs lead to permanent disability and
14% to a fatal outcome [2]. In a similar study focusing on
surgical adverse events, Gawande et al found AEs to occur
in up to 19% of surgical patients with 54% being prevent-
able. Even though the subgroup of patients undergoing
hip and knee replacement surgery had significantly fewer
AEs (5%), over half of them continued to be preventable
[1].
In 1999 the Institute of Medicine's (IOM) started one of
the largest efforts to improve patient safety. In its report
"To Err is Human", national directives for medical error
prevention and detection were established [3]. Following
this report, the Adult Joint Reconstruction service of our
institution started a prospective monitoring program to
assess adverse events and improve patient safety in the set-
ting of primary total hip replacement (THR). As part of an
earlier quality improvement project, a clinical pathway for
primary THR had already been developed in 1996, pro-
spective follow-up was nevertheless not performed from
that time to 2003.
In 2003 a prospective database was therefore started on
in-hospital adverse events for patients undergoing pri-
mary THR. Bi-monthly meetings were established in order
to periodically present outcomes to the teams involved in
delivery of care. Concurrently a retrospective review of
patients undergoing primary THR from 1997 to 2001 was
obtained as a control baseline.
The present manuscript compares the outcomes of the
periods 1997–2001 and 2003–2004. Since no changes
were introduced to the clinical pathway in the period
from 1997 to 2004 we hypothesized that the active mon-
itoring of outcomes in 2003 would lead to an initial
reduction in adverse events.
Methods
This is a prospective cohort study with a retrospective his-
torical control group. The period of enrolment was from
March 2003 to January 2004 for the prospective monitor-
ing group and January 1997 to December 2001 for retro-
spective controls. Patients undergoing primary THR were
included. Hip fractures and bone tumors as an indication
for THR were excluded. Prospective data was obtained
from patient charts, anesthesia and nursing records, and
admission and follow-up notes by a physician risk man-
ager (PNS). Bi-monthly meetings were held with individ-
uals involved in patient care in order to discuss registered
outcomes. Participants included attending physicians, res-
idents, nurses and operation room staff. Data for the con-
trol group was retrospectively extracted by two risk
management trained physicians (PNS and MP) from the
same sources.
Primary outcome measures were AEs occurring during the
in-hospital stay of patients undergoing primary THR. AEs
were defined according to Brennan et al as injuries that
occurred as a consequence to medical management and
that lead to a prolonged hospital stay and/or disability at
the time of discharge [2]. AEs therefore included surgical
site infections (SSI), venous thromboembolic events
(VTE), hip dislocations, adverse drug reactions and oligu-
ria. In order for AEs to be registered for the study, they had
to be entered by an attending or resident physician in the
medical record or by a nurse in the nursing records. Olig-
uria was established as urinary output of ≤1 ml/kg/h
according to nursing records.
No effort was done to establish the incidence of medical
error for each AE. Nevertheless adherence to venous
thromboembolic prophylaxis protocols was reviewed as a
measure for medical error, since non-adherence repre-
sents a deviation from the accepted standard of practice
dictated by the clinical pathway. For this purpose anesthe-
sia and nursing records were reviewed and non-justified
deviations from the established protocols registered.
Surgical pathway
The procedural protocol established for THR in 1996 at
our institution sets evidence based guidelines for antibi-
otic and VTE prophylaxis, surgical setup and rehabilita-
tion. Antibiotic prophylaxis is started with intravenous
(IV) infusion of either a first generation cephalosporin or
clindamycin 20 minutes before incision and is continued
QID for 24 hours or until removal of Foley catheter. VTE
prophylaxis includes gradual compression stockings and
low molecular weight heparin started preoperatively and
continued until 35 days after surgery. Skin preparation is
performed with iodophor soap and ointment and subse-
quent application of an iodophor impregnated adhesive.
Surgery is performed under horizontal laminar flow
through a posterolateral approach with capsule and exter-
nal rotator reinsertion. Implants used are either total
cemented or hybrid prostheses with non-cemented
acetabular fixation. Femoral head sizes used during the
study period were of either 22.25 or 28 mm diameter.
Rehablitation following a standard protocol is routinely
started on postoperative day one. All patients are dis-
charged home with a home-based rehabilitation program.
Statistical analysis
Chi-square and Fisher's exact test were used to compare
categorical variables between groups. Student's t-test wasPatient Safety in Surgery 2009, 3:7 http://www.pssjournal.com/content/3/1/7
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used to compare continuous data. Alpha-level of signifi-
cance was defined as less than 5% (p ≤ 0.05). Stata 9.0 for
Macintosh (StataCorp LP, College Station, TX) software
was used for the statistical analysis. Text for this section.
Results
The historical control group included 283 patients with a
mean age of 62 years (range 23–86). Two-hundred and six
patients (73%) were female and the most common indi-
cation for surgery was osteoarthritis. Procedures were per-
formed by a total of seven orthopedic surgeons, with an
average of 10 THRs per surgeon per year. Procedure vol-
ume per surgeon ranged from 3 to 50 THRs per year. A
total of 127 patients (45%) had at least one AE. The most
frequent AE were oliguria in 54 patients (19%), adverse
drug reactions in 31 (11%) and postoperative hip disloca-
tions in 17 patients (6%). VTE and SSI occurred in 8
patients (3%) each. Non-adherence to VTE prophylaxis
protocols was registered in 46 cases (15%).
Sixty-two patients with an average age of 68 years (range
45–90) underwent unilateral primary THRs during the
active monitoring study phase. Forty-five patients (73%)
were female and the most common indication for surgery
was osteoarthritis. Procedures were performed by a total
of five orthopedic surgeons, with an average of 12 THRs
per surgeon per the evaluated 10 month period. Proce-
dure volume during this time ranged from 2 to 52 THRs
per surgeon. At least one AE occurred in 13 patients
(21%). The most frequent AEs after monitoring had been
started were adverse drug reactions in 8 patients (13%)
and oliguria in 3 patients (5%). No hip dislocations,
infections or VTEs were registered during this period. Non
adherence to VTE prophylaxis protocols occurred in 1
patient (2%). Demographics and indications for surgery
are summarized in table 1.
The two groups were similar with regards to age, gender
and indication for surgery (p values 0.68, 0.94, and 0.56
respectively). A significant reduction in overall AE occur-
rence from 45% in the control group to 21% in the active
monitoring group was found (p < 0.001). Incidence of hip
dislocation was reduced from 6% to 0% (p = 0.05). Olig-
uria fell from 18.5% to 5% (p = 0.007), while SSI and VTE
were reduced from 3% to 0% (p = 0.37). Non-adherence
to VTE prophylaxis protocol went from 15% to 1.6% (p =
0.002). Adverse drug reaction increased from 11% to
13%, this difference was nevertheless not statistically sig-
nificant (p = 0.66). Results are summarized in table 1.
Discussion
Clinical pathways have been developed to improve effec-
tive resource use and preserve quality of care without com-
promising patient satisfaction or safety. Furthermore
pathways have shown to reduce hospital length-of-stay
[4]. Even though a clinical pathway was developed at our
institution in 1996, no active monitoring had been put in
place before 2003. Our retrospective review showed an
unacceptably high AE incidence of 45% during the period
1997–2001. THR specific AE included hip dislocations in
6%, and VTE and SSI in 3% and 3% of patients respec-
tively. In contrast, Philipps et al found dislocations to
occur in 4%, deep SSI in 0.2% and pulmonary embolism
in 0.9% of patients [5]. Their follow-up period of six
months is substantially longer than the in-hospital stay
reviewed for our study. In a nationwide study Zhan et al
Table 1: Demographics, indications and outcomes
Monitoring (n = 62) Control (n = 283) p-value
Age † 68 (45–90) 62 (23–86) 0.68
Gender *
Female 45 (73) 206 (73) 0.94
Male 17 (27) 77 (27)
Indication *
OA 52 (84) 220 (78) 0.56
RA 4 (6) 34 (12)
AVN 4 (6) 16 (6)
DDH 2 (3) 13 (5)
Adverse Event *
Any AE 13 (21) 127 (45) <0.001
Hip dislocation 0 (0) 17 (6) 0.05
Oliguria 3 (5) 54 (19) 0.007
SSI 0 (0) 8 (3) 0.37
VTE 0 (0) 8 (3) 0.37
ADR 8 (13) 31 (11) 0.66
VTEPP adherence * 61 (98) 241 (85) 0.002
Abbreviations: OA: osteoarthritis; RA: rheumatoid arhtritis; AVN: avascular necrosis of the femoral head; DDH: developmental displasia of the hip; 
AE: adverse event; SSI: surgical site infection; VTE: venous thromboembolic event; ADR: adverse drug reaction; VTEPP: venous thromboembolic 
event prophylaxis protocol; † values as means in years, ranges in parentheses; * values as number of patients, percentages in parentheses.Patient Safety in Surgery 2009, 3:7 http://www.pssjournal.com/content/3/1/7
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reviewed short term outcomes of patients undergoing
THR in 2003. In-hospital mortality was found to be
0.33%, while VTE occurred in 0.68%, decubitus ulcers in
0.28%, postoperative hemorrhage or hematoma in 0.05%
and infection in 0.05% [6]. Lassen et al reviewed the
occurrence of symptomatic venous thromboembolism at
11 days after elective THR. They found a 0.3% incidence
using a VTE prophylaxis regimen of enoxaparin 40 mg
subcutaneously started preoperatively [7]. This regimen is
similar to the one used at our institution and is therefore
a useful reference point. By these means, before starting
prospective monitoring of our pathway, frequencies were
unacceptably high for each of the listed AEs.
After starting active monitoring, overall rate of adverse
events as well as in-hospital hip dislocations, oliguria and
non-adherence to VTE prophylaxis protocols significantly
decreased. THR specific AEs even reached values similar to
those reported in the literature. Since no changes were
introduced to the clinical pathway during the periods
included in this study, the most likely explanations for
outcome improvement is the introduction of active mon-
itoring and feedback to the actors of delivery of care. The
phenomenon of increased performance derived from the
perception of being observed has been an extensive field
in industrial psychology. The landmark studies on pro-
ductivity at the Western Electrical Company's Hawthorne
Works in Chicago during the 1920s and 30s lead to the
finding that worker's performance increased as a conse-
quence to being singled out or to be made to feel impor-
tant [8]. As a consequence the term "Hawthorne Effect"
(HE) has been coined as an increase of an individual's
productivity secondary to an expression of interest in that
individual's performance [9].
In our study, the presence of an individual, in our case a
risk manager, prospectively recording patient AEs and out-
comes may have increased the alertness towards unsafe
practices. The feedback offered through bi-monthly meet-
ings may have further strengthened this effect. In this
sense a surgeon who is aware of hip dislocation rates
being measured and communicated to all team members
will be prone to make an additional effort in obtaining
the best operative results. Even though several factors not
controllable by the surgeon certainly influence the risk of
postoperative hip dislocation, several others, including
soft tissue tension and prosthetic alignment clearly
depend on the surgeon's task. Furthermore, nurses and
therapists will put an additional effort in avoiding maneu-
vers that may put the patient's hip stability at risk. This
same reasoning may hold true for the reduction of oligu-
ria, VTE and SSI as well as improvement of VTE prophy-
laxis protocol adherence.
One further remarkable finding of our study was the 15%
prevalence of non-adherence to VTE prophylaxis proto-
cols. This is of special importance, since protocols follow
evidence based management guidelines aimed at adverse
event reduction. Unjustified non-adherence to such a pro-
tocol would parallel not using a seat belt while driving an
automobile. While it does not always result in an unfavo-
rable outcome, it puts the patient at an unnecessary
risk[10]. Even though our study did not show improved
adherence to lead to a significant reduction of VTE, we
believe that a larger sample size would have shown a sig-
nificant effect. In this sense prospective monitoring
should have a strong impact on patient safety as it
increases protocol adherence as shown by the almost 10-
fold increase in VTE prophylaxis protocol adherence in
our study.
One limitation of our study is the relatively small sample
size of the prospective monitoring group. In January 2004
multiple modifications, like intraoperative intermittent
neumatic compression for VTE prophylaxis and use of
larger femoral heads, were introduced in the clinical path-
way. Since these changes would have altered the prospec-
tive group's homogeneity and hence its comparability
with the retrospective control group, we included only
patients operated before their introduction.
Conclusion
Even though the purpose of clinical pathways is to improve
effective resource use and increase patient satisfaction, our
study suggests that without active monitoring patient safety
can not be warranted. Prospective follow-up of outcomes
and regular follow-up to health care provider is essential to
reduce adverse events and improve patient safety.
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